Reduced in high-grade bladder cancer. Binds to fibroblast growth ftor receptor 1 (FGFR1) and abrogates lactate dehydrogenase phosphorylation, reducing glycolysis and inhibiting bladder cancer cell growth. This evidence concerns the gene FGFR1 and urinary bladder cancer.